RELATIONSHIP BETWEEN SERUM IRON, TOTAL IRON BINDING CAPACITY, TRANSFERRIN SATURATION AND HEPCIDIN IN PATIENTS WITH STAGE 3 - 5 NON-DIALYSIS CHRONIC KIDNEY DISEASE

被引:0
作者
Mardiana, N. [1 ]
Hertanto, D. M. [2 ]
机构
[1] Univ Airlangga, Dr Soetomo Gen Hosp Surabaya, Fac Med, Dept Internal Med,Div Nephrol & Hypertens, Jalan Mayjen Prof Dr Moestopo 6-8, Surabaya 62086, Indonesia
[2] Univ Airlangga, Dr Soetomo Gen Hosp Surabaya, Fac Med, Dept Internal Med, Surabaya, Indonesia
来源
NEW ARMENIAN MEDICAL JOURNAL | 2019年 / 13卷 / 04期
关键词
anemia; chronic kidney disease; hepcidin; serum iron; total iron binding capacity; transferrin saturation; ANEMIA; DISORDERS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Functional iron deficiency anemia is one of the complications that often occurs in patients with chronic kidney disease. Imbalance of hepcidin can induce iron disorder which is the pathophysiology of anemia in chronic kidney disease. Measurement of serum iron, total iron binding capacity and transferrin saturation aims to determine the availability of iron in the circulation. This study determines the relationship between serum iron, total iron binding capacity, transferrin saturation and hepcidin in non-dialysis chronic kidney disease. Objective: Determining the relationship between serum iron, total iron binding capacity, transferrin saturation and hepcidin in stage 3 - 5 non-dialysis chronic kidney disease. Methods: This cross-sectional analytic observational study evaluates 37 stage 3-5 non-dialysis chronic kidney disease patients whose age between 20 to 80 years old in outpatient nephrology clinic of Dr. Soetomo Hospital. Serum iron, total iron binding capacity, transferrin and hepcidin saturation levels are measured. This study is done by consecutive sampling and spearman parametric test is used to analyze the data. Results: Of the 37 subjects, 67.6% are men with mean age is 56.84 +/- 12.27 years. Most patients in this study is in stage 3. The mean hemoglobin, serum creatinine, serum iron and total iron binding capacity levels in the subjects of this study are 10.88 +/- 2.21 g/dl, 3.42 +/- 2.25 mg/dl, 64.86 +/- 24.15 mg/dl and 235.1 +/- 67.45 ng/dl consecutively. Median transferin saturation and hepcidin levels are 27% (4 - 88%) and 48.58 mg/dl (0.12 - 439.07 ng/ml). There is a relationship between total iron binding capacity and hepcidin with negative correlation coefficient of- 0.72 (p - 0.000). but there is no relationship between serum iron and transferrin saturation with hepcidin. Conclusion: In this study, there is a significant negative relationship with moderate strength between total iron binding capacity and hepcidin. The r value is -0.725 with p = 0.000.
引用
收藏
页码:95 / 99
页数:5
相关论文
共 15 条
  • [1] Hepcidin and iron disorders: new biology and clinical approaches
    Arezes, J.
    Nemeth, E.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 : 92 - 98
  • [2] Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort
    Atkinson, Meredith A.
    Kim, Ji Young
    Roy, Cindy N.
    Warady, Bradley A.
    White, Colin T.
    Furth, Susan L.
    [J]. PEDIATRIC NEPHROLOGY, 2015, 30 (04) : 635 - 643
  • [3] Mechanisms of Anemia in CKD
    Babitt, Jodie L.
    Lin, Herbert Y.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (10): : 1631 - 1634
  • [4] Risk factors of gender for renal progression in patients with early chronic kidney disease
    Chang, Po-Ya
    Chien, Li-Nien
    Lin, Yuh-Feng
    Wu, Mai-Szu
    Chiu, Wen-Ta
    Chiou, Hung-Yi
    [J]. MEDICINE, 2016, 95 (30)
  • [5] Hepcidin: clinical utility as a diagnostic tool and therapeutic target
    Coyne, Daniel W.
    [J]. KIDNEY INTERNATIONAL, 2011, 80 (03) : 240 - 244
  • [6] Anaemia of chronic disease
    Cullis, Jonathan
    [J]. CLINICAL MEDICINE, 2013, 13 (02) : 193 - 196
  • [7] Hepcidin and the Iron-Infection Axis
    Drakesmith, Hal
    Prentice, Andrew M.
    [J]. SCIENCE, 2012, 338 (6108) : 768 - 772
  • [8] Understanding anemia of chronic disease
    Fraenkel, Paula G.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 14 - 18
  • [9] Results of the European Survey on Anaemia Management 2003 (ESAM 2003): current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years
    Jacobs, C
    Frei, D
    Perkins, AC
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : III3 - III24
  • [10] Hepcidin and iron metabolism disorders in patients with chronic kidney disease
    Jefic, Marija
    Cvetkovic, Tatjana
    Djordjevic, Vidojko
    Damnjanovic, Goran
    Vlahovic, Predrag
    Kocic, Gordana
    Djindjic, Natasa
    Jovovic, Biljana
    Antic, Ana
    [J]. VOJNOSANITETSKI PREGLED, 2013, 70 (04) : 368 - 373